News

Announcements 07 October 2021

Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers

– Presentation highlights two biomarker approaches to identify patients with HER3-driven cancers that are sensitive to HER3 inhibition: the presence...

Announcements 23 September 2021

Hummingbird Bioscience opens new office and research facilities

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, has opened its new office...

Announcements 13 September 2021

Hummingbird Bioscience Announces US FDA Clearance of IND for First-in-Human Phase 1...

Houston, TX, and Singapore, September 13, 2021 – Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies...

Announcements 01 September 2021

Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief...

Houston, TX, and Singapore, September 1, 2021 – Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies...

Announcements 02 August 2021

Hummingbird Bioscience Announces UK MHRA Approval for First-in-Human Phase 1 Trial of...

– HMBD-001 is the first clinical stage asset generated by Hummingbird’s proprietary Rational Antibody Discovery (RAD) platform Houston and Singapore,...

Announcements 26 July 2021

Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch...

Houston and Singapore, July 26, 2021 – Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against...

Announcements 12 July 2021

Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration to Advance Innovative...

– Multi-year collaboration will investigate and evaluate Hummingbird’s HMBD-002 VISTA antagonist antibody Houston and Singapore, July 12, 2021 – Hummingbird...

Announcements 15 June 2021

Hummingbird Bioscience to Speak at 2021 Virtual Symposium: “VISTA: A New Immune...

Houston, TX, and Singapore, June 14, 2021 – Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies...